Vericel Corp Ord

Company Profile

Vericel Corp Ord had its IPO on 1997-02-04 under the ticker symbol VCEL.

The company operates in the Healthcare sector and Biotechnology industry. Vericel Corp Ord has a staff strength of 305 employees.

Stock update

Shares of Vericel Corp Ord opened at $34.07 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $34.06 - $36.87, and closed at $36.52.

This is a +7.22% increase from the previous day's closing price.

A total volume of 565,550 shares were traded at the close of the day’s session.

In the last one week, shares of Vericel Corp Ord have increased by +7.79%.

Vericel Corp Ord's Key Ratios

Vericel Corp Ord has a market cap of $1.62 billion, indicating a price to book ratio of 6.3809 and a price to sales ratio of 6.8909.

In the last 12-months Vericel Corp Ord’s revenue was $178.18 million with a gross profit of $109.79 million and an EBITDA of $-10459000. The EBITDA ratio measures Vericel Corp Ord's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vericel Corp Ord’s operating margin was -8.33% while its return on assets stood at -3.34% with a return of equity of -7.05%.

In Q2, Vericel Corp Ord’s quarterly earnings growth was a positive 34.3% while revenue growth was a positive 24%.

Vericel Corp Ord’s PE and PEG Ratio

Forward PE

370.3704

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-0.27 per share while it has a forward price to earnings multiple of 370.3704 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vericel Corp Ord’s profitability.

Vericel Corp Ord stock is trading at a EV to sales ratio of 7.2466 and a EV to EBITDA ratio of -70.3055. Its price to sales ratio in the trailing 12-months stood at 6.8909.

Vericel Corp Ord stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$310.71 million

Total Liabilities

$35.61 million

Operating Cash Flow

$-2408000.00

Capital Expenditure

$4.20 million

Dividend Payout Ratio

0%

Vericel Corp Ord ended 2023 with $310.71 million in total assets and $0 in total liabilities. Its intangible assets were valued at $310.71 million while shareholder equity stood at $198.93 million.

Vericel Corp Ord ended 2023 with $0 in deferred long-term liabilities, $35.61 million in other current liabilities, 612059000.00 in common stock, $-412510000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $43.02 million and cash and short-term investments were $97.83 million. The company’s total short-term debt was $7,218,000 while long-term debt stood at $0.

Vericel Corp Ord’s total current assets stands at $182.87 million while long-term investments were $20.99 million and short-term investments were $54.81 million. Its net receivables were $38.32 million compared to accounts payable of $14.40 million and inventory worth $13.88 million.

In 2023, Vericel Corp Ord's operating cash flow was $-2408000.00 while its capital expenditure stood at $4.20 million.

Comparatively, Vericel Corp Ord paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$36.52

52-Week High

$39.9

52-Week Low

$17.3

Analyst Target Price

$41

Vericel Corp Ord stock is currently trading at $36.52 per share. It touched a 52-week high of $39.9 and a 52-week low of $39.9. Analysts tracking the stock have a 12-month average target price of $41.

Its 50-day moving average was $34.77 and 200-day moving average was $30.92 The short ratio stood at 12.35 indicating a short percent outstanding of 0%.

Around 81.5% of the company’s stock are held by insiders while 10894.4% are held by institutions.